BeyondSpring Inc. Increase (Decrease) in Other Current Assets
BeyondSpring Inc. (BYSI) reported Increase (Decrease) in Other Current Assets of $11.00 thousand for the 9-month period ending 2017-09-30, per its 6-K filed 2017-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2017-11-09
- BeyondSpring Inc. increase (decrease) in other current assets for the quarter ending 2017-09-30 was -$32.00K, a 740.00% decline year-over-year.
- BeyondSpring Inc. increase (decrease) in other current assets for the quarter ending 2017-06-30 was $173.00K, a 1472.73% increase year-over-year.
- BeyondSpring Inc. increase (decrease) in other current assets for the quarter ending 2017-03-31 was -$130.00K, a 1281.82% decline year-over-year.
- BeyondSpring Inc. increase (decrease) in other current assets for the quarter ending 2016-09-30 was $5.00K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month |
|---|---|---|---|
| 2017-09-30 | -$32.00K derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09 | $141.00K derived: sum of 2 quarters · filed 2017-11-09 | $11.00K 6-K · filed 2017-11-09 |
| 2017-06-30 | $173.00K derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | $43.00K 6-K · filed 2017-08-21 | |
| 2017-03-31 | -$130.00K 6-K · filed 2017-05-22 | ||
| 2016-09-30 | $5.00K derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09 | $16.00K derived: sum of 2 quarters · filed 2017-11-09 | $27.00K 6-K · filed 2017-11-09 |
| 2016-06-30 | $11.00K derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | $22.00K 6-K · filed 2017-08-21 | |
| 2016-03-31 | $11.00K 6-K · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |